Company Filing History:
Years Active: 2025
Title: Grace Price: Innovator in Cancer Treatment
Introduction
Grace Price is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target DNA methyltransferase 1 (DNMT1). Her work is crucial in the fight against various diseases, including cancer.
Latest Patents
Grace Price holds 1 patent for her invention titled "Substituted pyridines as DNMT1 inhibitors." This invention relates to substituted pyridine derivatives that inhibit the activity of DNMT1. The patent also covers pharmaceutical compositions that include these compounds and outlines methods for using them in treating cancer, pre-cancerous syndromes, beta haemoglobinopathy disorders, and other diseases linked to inappropriate DNMT1 activity.
Career Highlights
Grace Price is associated with GlaxoSmithKline Intellectual Property Development Limited, where she applies her expertise in pharmaceutical innovation. Her work has positioned her as a key player in the development of new therapeutic strategies.
Collaborations
Throughout her career, Grace has collaborated with esteemed colleagues, including Andrew B Benowitz and David T Fosbenner. These partnerships have enhanced her research and contributed to the advancement of her inventions.
Conclusion
Grace Price exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to cancer treatment through her patented inventions highlight the importance of research and collaboration in developing effective therapies.